GENE ONLINE|News &
Opinion
Blog

Deals
Sherlock Biosciences Buys Sense Biodetection to Accelerate CRISPR-Based Handheld Diagnostic Tests
2023-02-02
CARsgen Taps Huadong to Commercialize Multiple Myeloma CAR-T in China
2023-01-17
Bayer Signs Up To Google Cloud To Boost Drug Discovery
2023-01-13
In-Home Kidney Disease Management Company, Monogram, Raises $375 Million
2023-01-13
JPM23: More Deals as JP Morgan Healthcare Conference 2023 Enters the Third Day
2023-01-12
JPM23: More Deals Defining JP Morgan Healthcare Conference 2023 Day Two
2023-01-11
JPM23: Development and Strategic Updates from JP Morgan Healthcare Conference 2023 Day Two
2023-01-10
JPM23: Partnerships Take off From JP Morgan Healthcare Conference 2023 Day One
2023-01-10
JPM23: Acquisition Announcements From JP Morgan Healthcare Conference 2023 Day One
2023-01-10
Italy’s Chiesi Buys Rare Disease Player Amryt For $1.48 Billion
2023-01-09
Following Amgen, Hummingbird Jumps Onto Synaffix’s ADC Platform In $150 Million Licensing Deal
2023-01-06
Soon-To-Be J&J Spinoff, Kenvue Files for $100 Million IPO
2023-01-06
Belharra Therapeutics Exits Stealth With $130 Million And A Genentech Deal
2023-01-05
PDS Buys IL-12 Targeting Therapy From Merck KGaA for $121 Million Biobucks
2023-01-04
GeneOnline’s Pick: Top 10 M&A Deals in 2022
2022-12-28
1 2 3 4 39
LATEST
OncoC4 Bags $200 Million In CTLA-4 Antibody Pact With BioNTech
2023-03-21
HHS Issues Initial Guidance on Negotiation Program as Government’s Latest Move to Reduce Drug Prices
2023-03-21
First-Ever Insect Brain Neuron Map Completed
2023-03-21
AbbVie Unveils Latest Data For Skyrizi In Difficult-To-Treat Psoriasis
2023-03-20
Sanofi Slashes Insulin Prices by Up to 78% Following Hot On the Heels of Major Competitors
2023-03-19
Novartis Snags Pediatric Brain Cancer Indication for Oncology Combination Therapy
2023-03-19
Pfizer, Astellas’ Prostate Cancer Drug Xtandi Achieves Goals In Phase 3
2023-03-19
Scroll to Top